Lesley‐Ann Martin
About
Lesley‐Ann Martin is a scholar working on Genetics, Oncology and Molecular Biology.
According to data from OpenAlex, Lesley‐Ann Martin has authored 80 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Genetics, 44 papers in Oncology and 36 papers in Molecular Biology. Recurrent topics in Lesley‐Ann Martin's work include Estrogen and related hormone effects (42 papers), HER2/EGFR in Cancer Research (19 papers) and Advanced Breast Cancer Therapies (17 papers). Lesley‐Ann Martin is often cited by papers focused on Estrogen and related hormone effects (42 papers), HER2/EGFR in Cancer Research (19 papers) and Advanced Breast Cancer Therapies (17 papers). Lesley‐Ann Martin collaborates with scholars based in United Kingdom, United States and Switzerland. Lesley‐Ann Martin's co-authors include Mitch Dowsett, Stephen Johnston, Sunil Pancholi, Neill Patani, Simak Ali, Ricardo Ribas, Ian Farmer, Isaac García-Murillas, Nicholas C. Turner and Giles Davies and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.
In The Last Decade
Lesley‐Ann Martin
79 papers receiving 3.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Lesley‐Ann Martin United Kingdom | 33 | 1.9k | 1.8k | 1.3k | 1.2k | 1.2k | 80 | 3.9k | ||
| Marja T. Nevalainen United States | 37 | 1.7k 0.9× | 1.8k 1.0× | 876 0.7× | 728 0.6× | 1.0k 0.9× | 77 | 3.7k | ||
| Sacha J. Howell United Kingdom | 35 | 2.1k 1.1× | 1.7k 0.9× | 1.0k 0.8× | 886 0.7× | 703 0.6× | 146 | 4.4k | ||
| Suleiman Massarweh United States | 22 | 2.1k 1.1× | 1.7k 0.9× | 877 0.7× | 1.5k 1.2× | 694 0.6× | 46 | 3.5k | ||
| Joseph A. Fontana United States | 45 | 1.6k 0.9× | 3.8k 2.1× | 1.0k 0.8× | 1.3k 1.0× | 694 0.6× | 144 | 6.0k | ||
| Rena G. Lapidus United States | 31 | 1.6k 0.9× | 3.4k 1.9× | 749 0.6× | 615 0.5× | 549 0.5× | 99 | 4.9k | ||
| Anna Tsimelzon United States | 33 | 2.6k 1.4× | 2.7k 1.5× | 2.1k 1.6× | 882 0.7× | 799 0.7× | 62 | 5.1k | ||
| Vessela N. Kristensen Norway | 37 | 1.4k 0.8× | 3.2k 1.8× | 2.3k 1.7× | 806 0.6× | 644 0.6× | 132 | 5.1k | ||
| Anne E. Lykkesfeldt Denmark | 39 | 1.4k 0.8× | 1.8k 1.0× | 803 0.6× | 1.4k 1.1× | 408 0.3× | 111 | 3.5k | ||
| J. Chuck Harrell United States | 35 | 1.8k 1.0× | 1.9k 1.1× | 1.1k 0.9× | 668 0.5× | 467 0.4× | 78 | 3.6k | ||
| Banu Arun United States | 23 | 1.8k 1.0× | 1.5k 0.8× | 897 0.7× | 800 0.6× | 466 0.4× | 58 | 3.3k |
Countries citing papers authored by Lesley‐Ann Martin
Since
Specialization
Citations
This map shows the geographic impact of Lesley‐Ann Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley‐Ann Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley‐Ann Martin more than expected).
Fields of papers citing papers by Lesley‐Ann Martin
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Lesley‐Ann Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley‐Ann Martin. The network helps show where Lesley‐Ann Martin may publish in the future.
Co-authorship network of co-authors of Lesley‐Ann Martin
This figure shows the co-authorship network connecting the top 25 collaborators of Lesley‐Ann Martin. A scholar is included among the top collaborators of Lesley‐Ann Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley‐Ann Martin. Lesley‐Ann Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Leal, Mariana Ferreira, Ben P. Haynes, Eugene F. Schuster, et al.. (2019). Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors. Clinical Cancer Research. 25(24). 7485–7496.
2.
Andrejeva, Gabriela, Sharon Gowan, Gigin Lin, et al.. (2019). De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy. Autophagy. 16(6). 1044–1060.
3.
Gao, Qiong, Maggie C.U. Cheang, James P. Morden, et al.. (2019). Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients. Breast Cancer Research. 22(1). 2–2.
4.
López‐Knowles, Elena, Alex Pearson, Eugene F. Schuster, et al.. (2018). Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations. British Journal of Cancer. 120(2). 247–255.
5.
Herrera-Abreu, María Teresa, Marta Palafox, Uzma Asghar, et al.. (2016). Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer. Cancer Research. 76(8). 2301–2313.
6.
Bacci, Marina, Elisa Giannoni, Antony Fearns, et al.. (2016). miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors. Cancer Research. 76(6). 1615–1626.
7.
Ribas, Ricardo, Sunil Pancholi, Stephanie K. Guest, et al.. (2015). AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo. Molecular Cancer Therapeutics. 14(9). 2035–2048.
8.
Patani, Neill, Anita K. Dunbier, H Anderson, et al.. (2014). Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer. Clinical Cancer Research. 20(15). 3962–3973.
9.
Gao, Qiong, Neill Patani, Anita K. Dunbier, et al.. (2014). Effect of Aromatase Inhibition on Functional Gene Modules in Estrogen Receptor–Positive Breast Cancer and Their Relationship with Antiproliferative Response. Clinical Cancer Research. 20(9). 2485–2494.
10.
Morandi, Andrea, Lesley‐Ann Martin, Qiong Gao, et al.. (2013). GDNF–RET Signaling in ER-Positive Breast Cancers Is a Key Determinant of Response and Resistance to Aromatase Inhibitors. Cancer Research. 73(12). 3783–3795.
11.
Patani, Neill, Maryou Lambros, Rachael Natrajan, et al.. (2011). Non-existence of caveolin-1 gene mutations in human breast cancer. Breast Cancer Research and Treatment. 131(1). 307–310.
12.
Banerjee, Susana, Roger A’Hern, Simone Detre, et al.. (2010). Biological Evidence for Dual Antiangiogenic-Antiaromatase Activity of the VEGFR Inhibitor PTK787/ZK222584 In vivo. Clinical Cancer Research. 16(16). 4178–4187.
13.
Léary, Alexandra, Suzanne Drury, Simone Detre, et al.. (2010). Lapatinib Restores Hormone Sensitivity with Differential Effects on Estrogen Receptor Signaling in Cell Models of Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer with Acquired Endocrine Resistance. Clinical Cancer Research. 16(5). 1486–1497.
14.
Tolhurst, Robert S., Ross S. Thomas, Hetal Patel, et al.. (2010). Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth. Breast Cancer Research and Treatment. 128(2). 357–368.
15.
Banerjee, Susana, Marketa Zvelebil, Pascal Furet, et al.. (2009). The Vascular Endothelial Growth Factor Receptor Inhibitor PTK787/ZK222584 Inhibits Aromatase. Cancer Research. 69(11). 4716–4723.
16.
Pancholi, Sunil, Caroline Hilmi, Susana Banerjee, et al.. (2008). ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2. Endocrine Related Cancer. 15(4). 985–1002.
17.
Johnston, Stephen R.D., Lesley‐Ann Martin, Alexandra Léary, Julia E. Head, & Mitch Dowsett. (2007). Clinical strategies for rationale combinations of aromatase inhibitors with novel therapies for breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 106(1-5). 180–186.
18.
Martin, Lesley‐Ann, Julia E. Head, Sunil Pancholi, et al.. (2007). The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo. Molecular Cancer Therapeutics. 6(9). 2458–2467.
19.
Martin, Lesley‐Ann, Ian Farmer, Stephen Johnston, Simak Ali, & Mitch Dowsett. (2005). Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation. Endocrine Related Cancer. 12(Supplement_1). S75–S84.
20.
Martin, Lesley‐Ann, Ian Farmer, Stephen Johnston, et al.. (2003). Enhanced Estrogen Receptor (ER) α, ERBB2, and MAPK Signal Transduction Pathways Operate during the Adaptation of MCF-7 Cells to Long Term Estrogen Deprivation. Journal of Biological Chemistry. 278(33). 30458–30468.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Marja T. Nevalainen Breakdown of academic impact, for papers by Sacha J. Howell Breakdown of academic impact, for papers by Suleiman Massarweh Breakdown of academic impact, for papers by Joseph A. Fontana Breakdown of academic impact, for papers by Rena G. Lapidus Breakdown of academic impact, for papers by Anna Tsimelzon Breakdown of academic impact, for papers by Vessela N. Kristensen Breakdown of academic impact, for papers by Anne E. Lykkesfeldt Breakdown of academic impact, for papers by J. Chuck Harrell Breakdown of academic impact, for papers by Banu Arun